Skip to content

KMTS KMTS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Abbott logo
AbbottABT
$116M-59.6%
Medtronic logo
MedtronicMDT
$97M-10.2%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$149K-91.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.78M-78.9%
Haemonetics logo
HaemoneticsHAE
$1.15M+127%
ICU Medical logo
ICU MedicalICUI
$0-100%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.32B+70.8%
Enterprise value$1.07B
P/S15.7×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: KMTS’s 10-K, filed July 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about KMTS's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's stock issuance proceeds?
KMTS (KMTS) reported stock issuance proceeds of $53.95M in Q1 2025.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.